A study conducted by Zhang et al. [148] demonstrated that a high grade of the pre-treatment serum ALB/FIB ratio combined with pre-treatment serum GGT/PLT ratio was independently associated with worse OS and RFS in HCC patients receiving curative surgical resection. This evidence concerns the gene ALB and hepatocellular carcinoma.